CDSCO UID MFG/MD/2018/000029_e7bb546ec4b612aacef8c521e317b268_f82f8f673f25f151ec57604d1e8aa4f0COVID-19 IgG/IgM Rapid Test
- UID
- MFG/MD/2018/000029_e7bb546ec4b612aacef8c521e317b268_f82f8f673f25f151ec57604d1e8aa4f0
- Device class
- Class D
- Brand name
- Gargle based
- License holder
- Meril Diagnostics Pvt. Ltd.
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- The Diagnostic Kit (Gargle based) for IgG/IgM Antibody to SARS-COV-2 is a rapid immunoassay for the qualitative detection of antibodies (Gargle based) to SARS-COV-2 virus in Whole Blood / Serum / Plasma
COVID-19 IgG/IgM Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2018/000029_e7bb546ec4b612aacef8c521e317b268_f82f8f673f25f151ec57604d1e8aa4f0. This device is marketed under the brand name Gargle based. The license holder is Meril Diagnostics Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.